Omada Health, Inc.(OMDA)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Omada Health, Inc. (OMDA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OMDA at 59.4/100 on a 32-signal composite quality model, placing it at rank #934 of 2,962 stocks — the top half of the AI-ranked universe. OMDA scores in the top quartile across earnings quality (97.4), revenue growth (83.5), institutional flow (80.4). Areas of concern include revenue scale (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 24.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Omada Health, Inc. reports quarterly revenue of $87.8M, net income of $5.3M, free cash flow of $3.9M. Top institutional holders of OMDA by reported 13-F value include Revelation Capital Management, Divisadero Street Capital Management, AMERICAN CENTURY COMPANIES, based on the most recent SEC filings. OMDA trades on the Nasdaq exchange and files with the SEC under CIK 1611115. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OMDA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Omada Health, Inc. directly from SEC EDGAR.